Global Synthetic Biology Technology Competitive Landscape Professional Research Report 2025
Research SummarySynthetic biology technology is an interdisciplinary field that combines principles of biology, genetics, engineering, and computer science to design, construct, and manipulate biological systems and organisms for various purposes. It involves the creation of artificial DNA sequences, the engineering of genes and genomes, and the development of biological circuits and systems to perform specific functions. Synthetic biology has a broad range of applications, including the development of biofuels, biopharmaceuticals, bioremediation, and the creation of customized organisms for scientific research. It also plays a role in genetic engineering and the design of genetically modified organisms (GMOs). Synthetic biology technology holds immense potential for solving complex problems in fields such as healthcare, agriculture, and environmental science, offering innovative solutions by harnessing the power of biological systems.
According to DIResearch's in-depth investigation and research, the global Synthetic Biology Technology market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Synthetic Biology Technology include Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, Eurofins Genomics, Genewiz, Synthetic Genomics, Twist Bioscience, ATUM, MGI International Sales Co., Ltd, Cathay Biotech Inc, Novogene Co., Ltd, Anhui Huaheng Biotechnology Co., Ltd, GenScript Biotech Corporation, Bloomage Biotechnology, BBI Life Sciences Corporation, Tsingke Biotechnology, Abiochem Biotechnology, Singleron Biotechnologies Co., Ltd, CABIO Biotech (Wuhan) Co., Ltd, Bluepha, Suzhou Leadsynbio Technology, Shenzhen Readline Biotech Co., Ltd, BONG YONG KOY, Shenzhen Siyomicro Bio-Tech Co., Ltd, PhaBuilder, SENRUIS, Suzhou Hongxun Biotechnologies, Dynegene Technologies etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Synthetic Biology Technology. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Synthetic Biology Technology market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Synthetic Biology Technology market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Synthetic Biology Technology industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Synthetic Biology Technology Include:
Integrated DNA
Ginkgo Bioworks
Agilent
Thermo Fisher
Eurofins Genomics
Genewiz
Synthetic Genomics
Twist Bioscience
ATUM
MGI International Sales Co., Ltd
Cathay Biotech Inc
Novogene Co., Ltd
Anhui Huaheng Biotechnology Co., Ltd
GenScript Biotech Corporation
Bloomage Biotechnology
BBI Life Sciences Corporation
Tsingke Biotechnology
Abiochem Biotechnology
Singleron Biotechnologies Co., Ltd
CABIO Biotech (Wuhan) Co., Ltd
Bluepha
Suzhou Leadsynbio Technology
Shenzhen Readline Biotech Co., Ltd
BONG YONG KOY
Shenzhen Siyomicro Bio-Tech Co., Ltd
PhaBuilder
SENRUIS
Suzhou Hongxun Biotechnologies
Dynegene Technologies
Synthetic Biology Technology Product Segment Include:
Gene Synthesis
Oligonucleotide Synthesis
Bioinformatics Analysis
DNA Assembly
Synthetic Biology Technology Product Application Include:
Medicine
Chemical Industry
Agriculture
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Synthetic Biology Technology Industry PESTEL Analysis
Chapter 3: Global Synthetic Biology Technology Industry Porter’s Five Forces Analysis
Chapter 4: Global Synthetic Biology Technology Major Regional Market Size and Forecast Analysis
Chapter 5: Global Synthetic Biology Technology Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Synthetic Biology Technology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Synthetic Biology Technology Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources